CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-06 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +6,454 | 6,454 | ||
| 2026-05-06 | Nader Francois Director | Grant or award · Restricted Stock Units | +4,185 | 4,185 | ||
| 2026-04-30 | Nader Francois Director | Exercise or conversion | +12,174 | 32,781 | ||
| 2026-04-30 | Nader Francois Director | Exercise or conversion · Restricted Stock Units | −12,174 | 0 | ||
| 2025-04-30 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +6,378 | 6,378 | ||
| 2025-04-30 | Nader Francois Director | Grant or award · Restricted Stock Units | +12,174 | 12,174 | ||
| 2024-05-06 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +7,557 | 7,557 | ||
| 2023-05-03 | Nader Francois Director | Grant or award · Stock Option (Right to Buy) | +6,134 | 6,134 |
Page 1 of 1 · 8 trades